title: [Practices and attitudes regarding HPV vaccination among general practitioners from Besançon].
abstract: OBJECTIVE
  To assess opinions, practices and difficulties of general practitioners (GP) of Besançon concerning human papillomavirus (HPV) vaccination.
  
  
  METHODS
  A survey among the 140 GP of Besançon, France, was conducted in 2015.
  
  
  RESULTS
  A percentage of 77.1 reported being favourable to HPV vaccination and 72.9% practices HPV vaccination. The 2 main concerns about HPV vaccination for GP are the fear of side effects (for 40.6% of GP) and the doubt on efficacy. According to GP, the hepatitis B vaccination controversy, the fear of side effects, the limited clinical efficacy experience and the lack of confidence in health authorities are concerns about HPV vaccination for 77.1%, 76%, 74% and 49% of patients, respectively.
  
  
  CONCLUSIONS
  Courses for GP on HPV vaccination must be pursued and reinforced. A school-based program could be developed to facilitate communication between GP and patients to improve HPV vaccination coverage.
authors.affiliation: Unité de méthodologie et qualité de vie en cancérologie, centre hospitalier universitaire de Besançon, 25000 Besançon, France.
authors.forename: P
authors.initials: P
authors.lastname: Bouvret
authors.affiliation: Université Franche-Comté, COMUE uB-FC, 25000 Besançon, France; CHRU de Besançon, 25000 Besançon, France; EA 3181, LabEx LipSTIC ANR-11-LABX-0021, FED4234, Inserm CIC-1431, 25000 Besançon, France.
authors.forename: C
authors.initials: C
authors.lastname: Mougin
authors.affiliation: Université Franche-Comté, COMUE uB-FC, 25000 Besançon, France; CHRU de Besançon, 25000 Besançon, France; EA 3181, LabEx LipSTIC ANR-11-LABX-0021, FED4234, Inserm CIC-1431, 25000 Besançon, France.
authors.forename: J-L
authors.initials: JL
authors.lastname: Prétet
authors.affiliation: Unité de méthodologie et qualité de vie en cancérologie, centre hospitalier universitaire de Besançon, 25000 Besançon, France.
authors.forename: A
authors.initials: A
authors.lastname: Meurisse
authors.affiliation: Unité de méthodologie et qualité de vie en cancérologie, centre hospitalier universitaire de Besançon, 25000 Besançon, France; EA 3181, LabEx LipSTIC ANR-11-LABX-0021, FED4234, Inserm CIC-1431, 25000 Besançon, France.
authors.forename: F
authors.initials: F
authors.lastname: Bonnetain
authors.affiliation: Unité de méthodologie et qualité de vie en cancérologie, centre hospitalier universitaire de Besançon, 25000 Besançon, France; Service d'oncologie médicale, centre hospitalier universitaire de Besançon, 3, boulevard Fleming, 25000 Besançon, France. Electronic address: fredericfiteni@gmail.com.
authors.forename: F
authors.initials: F
authors.lastname: Fiteni
mesh_terms: D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D005260:Female; D005602:France; D058005:General Practitioners / Q000706:statistics & numerical data*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000627:therapeutic use*; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D053918:Papillomavirus Vaccines
keywords: Couverture vaccinale; Coverage; General practitioner; Human papillomavirus; Médecin traitant; Papillomavirus; Prevention; Prévention; Vaccin; Vaccine